The presence of anaemia, in other words, low levels of haemoglobin concentration (Hb) or haematocrit (HTC), has been considered as a proxy for iron-deficiency and widely used to estimate its prevalence and to indicate and evaluate the iron-therapy during pregnancy [3, 4], especially in developing countries [4, 5]. The gene discussed is GSTM1; the disease is anemia (phenotype).